FINWIRES · TerminalLIVE
FINWIRES

Teva Pharmaceutical Industries Insider Sold Shares Worth $321,547, According to a Recent SEC Filing

By

Matthew Shields, Executive Vice President, Global Operations, on June 18, 2026, sold 9,989 shares in Teva Pharmaceutical Industries (TEVA) for $321,547.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000119312526277490/xslF345X05/ownership.xml

Related Articles